</ref> The first [[excimer laser]] used a xenon [[Dimer (chemistry)|dimer]] (Xe<sub>2</sub>) energized by a beam of electrons to produce [[stimulated emission]] at an [[ultraviolet]] wavelength of 176 [[nanometre|nm]].<ref name="basov">
</ref>
Xenon chloride and xenon fluoride have also been used in excimer (or, more accurately, exciplex) lasers.[ref]
</ref> The xenon chloride excimer laser has been employed, for example, in certain dermatological uses.<ref>
</ref>

===Medical===

====Anesthesia====

Xenon has been used as a general anesthetic. Although it is expensive, anesthesia machines that can deliver xenon are about to appear on the European market, because advances in recovery and recycling of xenon have made it economically viable.[tpl]cite journal|last=Tonner|first=P. H.|title=Xenon: one small step for anaesthesia ... ? (editorial review)|journal=Current Opinion in Anaesthesiology|year=2006|volume=19|issue=4|pages=382–4|doi=10.1097/01.aco.0000236136.85356.13|pmid=16829718[/tpl]
Xenon interacts with many different receptors and ion channels and like many theoretically multi-modal inhalation anesthetics these interactions are likely complementary. Xenon is a high-affinity glycine-site NMDA receptor antagonist.[tpl]cite journal|title=Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia|journal=Anesthesiology|pmid=20124979|year=2010|last1=Banks|first1=P|last2=Franks|first2=NP|last3=Dickinson|first3=R|volume=112|issue=3|pages=614–22|doi=10.1097/ALN.0b013e3181cea398[/tpl]   However, xenon distinguishes itself from other clinically used NMDA receptor antagonists in its lack of neurotoxicity and its ability to inhibit the neurotoxicity of ketamine and nitrous oxide.[tpl]cite journal|title=Neuroprotective and neurotoxic properties of the 'inert' gas, xenon|journal=Br J Anaesth|pmid=12393773|year=2002|last1=Ma|first1=D|last2=Wilhelm|first2=S|last3=Maze|first3=M|last4=Franks|first4=NP|volume=89|issue=5|pages=739–46|doi=10.1093/bja/89.5.739[/tpl][tpl]cite journal|title=Xenon inhibits but N(2)O enhances ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices|journal=Anesth Analg.|pmid=11159233|year=2001|last1=Nagata|first1=A|last2=Nakao Si|first2=S|last3=Nishizawa|first3=N|last4=Masuzawa|first4=M|last5=Inada|first5=T|last6=Murao|first6=K|last7=Miyamoto|first7=E|last8=Shingu|first8=K|volume=92|issue=2|pages=362–8|doi=10.1213/00000539-200102000-00016[/tpl]   Unlike ketamine and nitrous oxide, xenon does not stimulate a dopamine efflux from the nucleus accumbens.[tpl]cite journal|title=The differential effects of nitrous oxide and xenon on extracellular dopamine levels in the rat nucleus accumbens: a microdialysis study|journal=Anesth Analg|pmid=17122223|year=2006|last1=Sakamoto|first1=S|last2=Nakao|first2=S|last3=Masuzawa|first3=M|last4=Inada|first4=T|last5=Maze|first5=M|last6=Franks|first6=NP|last7=Shingu|first7=K|volume=103|issue=6|pages=1459–63|doi=10.1213/01.ane.0000247792.03959.f1[/tpl] Like nitrous oxide and cyclopropane xenon activates the two-pore domain potassium channel TREK-1.  A related channel TASK-3 also implicated in anesthetic actions is insensitive to xenon.[tpl]cite journal|title=Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane|journal=Mol Pharmacol |pmid=14742687|year=2004|last1=Gruss|first1=M|last2=Bushell|first2=TJ|last3=Bright|first3=DP|last4=Lieb|first4=WR|last5=Mathie|first5=A|last6=Franks|first6=NP|volume=65|issue=2|pages=443–52|doi=10.1124/mol.65.2.443[/tpl]   Xenon inhibits nicotinic acetylcholine alpha4beta2 receptors which contribute to spinally mediated analgesia.[tpl]cite journal|title=Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol|journal=Anesthesiology|pmid=11020766|year=2000|last1=Yamakura|first1=T|last2=Harris|first2=RA|volume=93|issue=4|pages=1095–101|doi=10.1097/00000542-200010000-00034[/tpl][tpl]cite journal|title=Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice|journal=Pain|pmid=16781069|year=2006|last1=Rashid|first1=MH|last2=Furue|first2=H|last3=Yoshimura|first3=M|last4=Ueda|first4=H|volume=125|issue=1–2|pages=125–35|doi=10.1016/j.pain.2006.05.011[/tpl]   Xenon is an effective inhibitor of plasma membrane Ca2+ ATPase.  Xenon inhibits Ca+ ATPase by binding to a hydrophobic pore within the enzyme and preventing the enzyme from assuming active conformations.[tpl]cite journal|coauthors=Maria M. Lopez and  Danuta Kosk-Kosicka|title=How Do Volatile Anesthetics Inhibit Ca2+-ATPases?|journal=The Journal of Biological Chemistry, 270, 28239-28245.|year=1995|doi=10.1074/jbc.270.47.28239|url=http://www.jbc.org/content/270/47/28239.full|last1=Kosk-Kosicka|first1=D.|volume=270|issue=47|pages=28239[/tpl]
Xenon is a competitive inhibitor of serotonin 5HT3.  While neither anesthetic nor antinociceptive this activity reduces anesthesia-emergent nausea and vomiting.[tpl]cite journal|title=The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes|journal=Anesthesiology|pmid=11873047|year=2002|last1=Suzuki|first1=T|last2=Koyama|first2=H|last3=Sugimoto|first3=M|last4=Uchida|first4=I|last5=Mashimo|first5=T|volume=96|issue=3|pages=699–704|doi=10.1097/00000542-200203000-00028[/tpl]
Xenon has a minimum alveolar concentration (MAC) of 72% at age 40, making it 44% more potent than N2O as an anesthetic.[tpl]Cite journal|last=Nickalls |first=R. W. D|coauthors=Mapleson, W.W.|title=Age‐related iso‐MAC charts for isoflurane, sevoflurane and desflurane in man|journal= British Journal of Anesthesiology|url=http://bja.oxfordjournals.org/content/91/2/170/T1.expansion.html[/tpl] Thus it can be used in concentrations with oxygen that have a lower risk of hypoxia. Unlike nitrous oxide (N2O), xenon is not a greenhouse gas and so it is also viewed as environmentally friendly.[tpl]Cite journal|last=Goto|first=T|coauthors=Nakata Y, Morita S|title=Will xenon be a stranger or a friend?: the cost, benefit, and future of xenon anesthesia|journal=Anesthesiology|volume=98|issue=1|pages=1–2|year=2003|pmid=12502969|url=http://journals.lww.com/anesthesiology/Fulltext/2003/01000/Will_Xenon_Be_a_Stranger_or_a_Friend___The_Cost,.2.aspx|accessdate=2010-09-15|doi=10.1097/00000542-200301000-00002[/tpl] Xenon vented into the atmosphere is being returned to its original source, so no environmental impact is likely.

====Neuroprotectant====

Xenon induces robust cardioprotection and  neuroprotection through a variety of mechanisms of action.  Through its influence on Ca2+, K+, KATP\HIF and NMDA antagonism xenon is neuroprotective when administered before, during and after ischemic insults.[tpl]cite journal|title=Xenon Attenuates Cerebral Damage after Ischemia in Pigs|date=May 2005 | volume = 102 |issue= 5 |pages= 929–936|url=http://journals.lww.com/anesthesiology/fulltext/2005/05000/xenon_attenuates_cerebral_damage_after_ischemia_in.11.aspx[/tpl][tpl]cite journal|title=Xenon Provides Short-Term Neuroprotection in Neonatal Rats When Administered After Hypoxia-Ischemia|journal=Stroke. 2006; 37: 501-506|url=http://stroke.ahajournals.org/content/37/2/501.abstract|pmid=16373643|doi=10.1161/01.STR.0000198867.31134.ac|year=2006|last1=Dingley|first1=J|last2=Tooley|first2=J|last3=Porter|first3=H|last4=Thoresen|first4=M|volume=37|issue=2|pages=501–6[/tpl]  Xenon is a high affinity antagonist at the NMDA receptor glycine site. Xenon is cardioprotective in ischemia-reperfusion conditions by inducing pharmacologic non-ischemic preconditioning.  Xenon is cardioprotective by activating PKC-epsilon & downstream p38-MAPK.[tpl]cite journal|title=The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK|journal=Br J Pharmacol|pmid=15644876|year=2005|last1=Weber|first1=NC|last2=Toma|first2=O|last3=Wolter|first3=JI|last4=Obal|first4=D|last5=Müllenheim|first5=J|last6=Preckel|first6=B|last7=Schlack|first7=W|volume=144|issue=1|pages=123–32|doi=10.1038/sj.bjp.0706063|pmc=1575984[/tpl]  Xenon mimics neuronal ischemic preconditioning by activating ATP sensitive potassium channels.[tpl]cite journal|title=Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels|journal=Anesthesiology|pmid=19352153|year=2009|last1=Bantel|first1=C|last2=Maze|first2=M|last3=Trapp|first3=S|volume=110|issue=5|pages=986–95|doi=10.1097/ALN.0b013e31819dadc7|pmc=2930813[/tpl]  Xenon allosterically reduces ATP mediated channel activation inhibition independently of the sulfonylurea receptor1 subunit, increasing KATP open-channel time and frequency.[tpl]cite journal|title=Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener|journal=Anesthesiology|pmid=20179498|year=2010|last1=Bantel|first1=C|last2=Maze|first2=M|last3=Trapp|first3=S|volume=112|issue=3|pages=623–30|doi=10.1097/ALN.0b013e3181cf894a|pmc=2935677[/tpl]
Xenon upregulates hypoxia inducible factor 1 alpha (HIF1a).
Xenon gas was added as an ingredient of the ventilation mix for a newborn baby at St. Michael's Hospital, Bristol, England, whose life chances were otherwise very compromised, and was successful, leading to the authorisation of clinical trials for similar cases.[ref]
